Karyopherinα2 (KPNA2) has been validated to be elevated in various cancers, including cervical carcinoma [27], esophageal cancer [28], lung cancer [29] and hepatocellular carcinoma [30]. This evidence concerns the gene KPNA2 and hepatocellular carcinoma.